Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Interleukin-6 may play a role in causing alopecia areata.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

TNF-alpha inhibitors can cause various immune-related skin issues.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Tertiary lymphoid structures are important in immunotherapy and need more research.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Hair follicles in mice help detect and respond to germs.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Tattoos may trigger autoimmune symptoms in some people.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Alopecia areata might help slow down certain cancers.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Certain gene variations may increase the risk and severity of alopecia areata.

ECM-inspired wound dressings can help heal chronic wounds by controlling macrophage activity.